ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevention of Weight Gain in University Students (PGP2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00995462
Recruitment Status : Completed
First Posted : October 15, 2009
Last Update Posted : December 11, 2013
Sponsor:
Collaborators:
Canadian Diabetes Association
Danone Institute
Information provided by (Responsible Party):
Marie-France Hivert, Université de Sherbrooke

Brief Summary:
This study assess whether a small-group seminar intervention to prevent weight gain is effective in a general university student population, and to address the relative role of biological vs. lifestyle factors in predicting weight gain in humans.

Condition or disease Intervention/treatment Phase
Prevention Weight Gain Behavioral: Lifestyle intervention seminars Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 319 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Prevention of Weight Gain in University Students
Study Start Date : September 2006
Actual Primary Completion Date : October 2011
Actual Study Completion Date : December 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Body Weight
U.S. FDA Resources

Arm Intervention/treatment
No Intervention: Control
Experimental: Small-group seminar for 2 years Behavioral: Lifestyle intervention seminars
The first sessions emphasize acquisition of new knowledge during interactive group seminars designed to maximize attendant's participation by adapting wellknown quiz-show or parlour games to deliver key concepts. A number of sessions are aimed at increasing self-efficacy through problem-solving, time-management strategies, individual self monitoring and goal-setting.During the second year, the intervention focuses on maintenance of healthy behaviour with empowerment of the participants using problem-solving, goal-setting, planning, and self-monitoring skills.
Experimental: Small-group seminars for 1 year followed by email intervention Behavioral: Lifestyle intervention seminars
The first sessions emphasize acquisition of new knowledge during interactive group seminars designed to maximize attendant's participation by adapting wellknown quiz-show or parlour games to deliver key concepts. A number of sessions are aimed at increasing self-efficacy through problem-solving, time-management strategies, individual self monitoring and goal-setting.During the second year, the intervention focuses on maintenance of healthy behaviour with empowerment of the participants using problem-solving, goal-setting, planning, and self-monitoring skills.



Primary Outcome Measures :
  1. Weight change [ Time Frame: 2 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • First year students at the Université de Sherbrooke.

Exclusion Criteria:

  • Presence of diseases or medications that would be expected to affect weight (cystic fibrosis, diabetes, inflammatory bowel diseases, anorexia nervosa, bulimia, etc.).
  • Pregnancy or planning a pregnancy in the next two years.
  • Unable to give an informed consent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00995462


Locations
Canada, Quebec
Université de Sherbrooke
Sherbrooke, Quebec, Canada, J1K 2R1
Sponsors and Collaborators
Marie-France Hivert
Canadian Diabetes Association
Danone Institute
Investigators
Principal Investigator: Marie-France Langlois, MD Université de Sherbrooke

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Marie-France Hivert, MD, Université de Sherbrooke
ClinicalTrials.gov Identifier: NCT00995462     History of Changes
Other Study ID Numbers: 05-025
First Posted: October 15, 2009    Key Record Dates
Last Update Posted: December 11, 2013
Last Verified: December 2013

Additional relevant MeSH terms:
Body Weight
Weight Gain
Signs and Symptoms
Body Weight Changes